United States
Germany
Japan
United Kingdom
China
Recombinant Anti-CD64 (Clone H22)
| Applications | CT, FC |
| Reactivities | Human |
Products
Recombinant Anti-CD64 (Clone H22)
| Applications | CT, FC |
| Reactivities | Human |
Recombinant Anti-CD64 (Clone H22)
| Applications | CT, FC |
| Reactivities | Human |
Recombinant Anti-CD64 (Clone H22)
| Applications | CT, FC |
| Reactivities | Human |
